The US Food and Drug Administration (FDA) has received several reports of side effects, including respiratory problems and death following the use of botulinum toxins types A and B for both FDA-approved and unapproved use. … [Read more...]
Search Results for: labeling
Avandia Heart Atacks Link- Drug for Diabetics May Increase Risk by 40 Percent
The US Food and Drug Administration issued a safety alert for Avandia, a widely prescribed drug to treat type-2 diabetics. According to FDA, Studies show that there is "a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia." By "potentially significant" they are referring to the 30% - 40% … [Read more...]
Antidepressants and Suicidal Thoughts
The Food and Drug Administration (FDA) has proposed that the labels on all antidepressant medications be updated to include warnings about the increased risk of suicidal thinking and behavior in teenagers and young adults during the first two months of treatment.Makers of antidepressant medications now have 30 days to submit their revised product … [Read more...]
Rituxan -Rituximab- URGENT Pharmaceutical Recall Alert
The FDA has issued an alert for Rituxan (Rituximab) after reports of a life-threatening brain infection in patients with systemic lupus erythematosus after treatment with Rituxan.The FDA has received reports of the death of two patients who were treated with Rituxan for systemic lupus erythematosus (SLE). Both patients developed a life-threatening … [Read more...]
High ESA Doses Can Kill – FDA Report
FDA notified healthcare professionals of a newly published clinical study showing that patients treated with an erythropoiesis-stimulating agent (ESA) and dosed to a target hemoglobin concentration of 13.5 g/dL are at a significantly increased risk for serious and life threatening cardiovascular complications, as compared to use of the ESA to … [Read more...]
Recent Comments